文献速递神经MR

ReSPOND联盟中IDH1野生型4级胶质瘤患者的性别特异性差异

Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium.
PubMed 文献 · AJNR Am J Neuroradiol · 2024-09-09

基于ReSPOND联盟1832例IDH1野生型4级胶质瘤患者的回顾性数据,评估分子、临床及影像肿瘤参数的性别差异及生存结局。女性诊断年龄中位数64岁高于男性61.9岁,男性KPS高于80者比例更高,女性增强、坏死核心及水肿体积均低于男性;生存结局无性别差异,性别非独立预后因素。

要点

  • 女性IDH1野生型4级胶质瘤诊断年龄中位数64岁,男性61.9岁(FDR=0.003)。
  • 女性增强体积16.7 cm³、坏死核心6.18 cm³、水肿46.9 cm³,均低于男性(FDR≤0.001)。
  • 男性KPS>80者占69.7%,女性占60.4%(FDR=0.044);生存结局无性别差异。

核心结论

  • IDH1野生型4级胶质瘤的临床和影像肿瘤参数存在显著性别差异,但性别不是生存结局的独立预后因素,影响男性和女性患者结局的肿瘤参数相同。

研究设计与样本

  • 回顾性研究,数据来自ReSPOND联盟(Radiomics Signatures for Precision Oncology in Glioblastoma),纳入1832例IDH1野生型4级胶质瘤患者,对缺失值进行数据插补,使用非参数检验评估性别差异,术前MRI生成空间图谱,生存分析采用log-rank检验和Cox比例风险分析。

关键影像表现/征象

  • 女性增强肿瘤体积16.7 cm³、坏死核心体积6.18 cm³、水肿区体积46.9 cm³,均低于男性(FDR分别为0.001、0.001、0.0001)。
  • 总体人群中最常见肿瘤中心位于右侧颞叶,男性和女性右侧及左侧颞叶均更常受累。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Understanding sex-based differences in patients with glioblastoma is necessary for accurate personalized treatment planning to improve patient outcomes. Our purpose was to investigate sex-specific differences in molecular, clinical, and radiologic tumor parameters, as well as survival outcomes in patients with glioblastoma, isocitrate dehydrogenase-1 wild-type (IDH1-WT), grade 4.

MATERIALS AND METHODS: Retrospective data of 1832 patients with glioblastoma, IDH1-WT with comprehensive information on tumor parameters was acquired from the Radiomics Signatures for Precision Oncology in Glioblastoma consortium. Data imputation was performed for missing values. Sex-based differences in tumor parameters, such as age, molecular parameters, preoperative Karnofsky performance score (KPS), tumor volumes, epicenter, and laterality were assessed through nonparametric tests. Spatial atlases were generated by using preoperative MRI maps to visualize tumor characteristics. Survival time analysis was performed through log-rank tests and Cox proportional hazard analyses.

RESULTS: Glioblastoma was diagnosed at a median age of 64 years in women compared with 61.9 years in men (false discovery rate [FDR] = 0.003). Men had a higher KPS (above 80) as compared with women (60.4% women versus 69.7% men, FDR = 0.044). Women had lower tumor volumes in enhancing (16.7 cm3 versus 20.6 cm3 in men, FDR = 0.001), necrotic core (6.18 cm3 versus 7.76 cm3 in men, FDR = 0.001), and edema regions (46.9 cm3 versus 59.2 cm3 in men, FDR = 0.0001). The right temporal region was the most common tumor epicenter in the overall population. Right as well as left temporal lobes were more frequently involved in men. There were no sex-specific differences in survival outcomes and mortality ratios. Higher age, unmethylated O6-methylguanine-DNA-methyltransferase promoter and undergoing subtotal resection increased the mortality risk in both men and women.

CONCLUSIONS: Our study demonstrates significant sex-based differences in clinical and radiologic tumor parameters of patients with glioblastoma. Sex is not an independent prognostic factor for survival outcomes and the tumor parameters influencing patient outcomes are identical for men and women.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Gongala S, Garcia JA, Korakavi N, et al. Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium. AJNR Am J Neuroradiol. 2024. PMID: 38684319. doi:10.3174/ajnr.A8319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。